SEC Form D · filed November 18, 2014
Brighton Biotech, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Jeffrey H. Gelfand · Forth Worth, TXDirectorFrancis J. West · Forth Worth, TXDirectorAshley H. Bush · Forth Worth, TXExecJurij H. Petrin · Forth Worth, TXDirectorJohn J. White · Forth Worth, TXDirectorKevin H. Hershberger · Forth Worth, TXExec · DirectorHalden H. Conner · Forth Worth, TXExec · DirectorCraig H. Rosenfeld · Forth Worth, TXExecMarika X. Tonay · New York, NYExecJohn P. O'Shea · New York, NYExec · DirectorRobert E. Hermanson · St. Louis, MOExec · DirectorJared Kushner · New York, NYExec · DirectorRandy R. Rhoden · Huntington Beach, CADirectorValue Partners Hong Kong Limited · Hong Kong, Hong KongDirectorNigel D. Stead · Singapore, U0Exec · DirectorKee Chong K. Li · R Hill, O4Exec · DirectorSteven S. Russo · Houston, TXExec · DirectorEdward R. Allen, Iii · Houston, TXExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗